Small Pharma gets approval for in-human injectable DMT trial

Mugglehead
By Rowan DunneOct 31, 2022, 6:24 pm202 pts
Biotechnology company, Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) has achieved an “exciting milestone” in its mission to progress drugs derived from dimethyltryptamine. On Monday, the company announced that it had been granted approval from the Research Ethics Committee and U.K. Medicines and Healthcare…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Nevada opens foster parenting to those with cannabis records 41

Exclusive Interview with Josh Kesselman, the New Owner of High Times 30

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.